Invention Grant
- Patent Title: Methods of using IGFIR and ABL kinase modulators
- Patent Title (中): 使用IGFIR和ABL激酶调节剂的方法
-
Application No.: US12306606Application Date: 2007-07-03
-
Publication No.: US08222256B2Publication Date: 2012-07-17
- Inventor: Wentao Zhang
- Applicant: Wentao Zhang
- Applicant Address: US CA South San Francisco
- Assignee: Exelixis, Inc.
- Current Assignee: Exelixis, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/US2007/015585 WO 20070703
- International Announcement: WO2008/005538 WO 20080110
- Main IPC: A61K31/4965
- IPC: A61K31/4965
Abstract:
The invention provides methods of treating cancer with a compound which inhibits kinases, more specifically IGF1R and Abl, in combination with treatments(s) selected from surgery, radiation, monoclonal antibody, bone marrow or peripheral blood stem cell transplantation, and one or more chemotherapeutic agent(s).
Public/Granted literature
- US20090232828A1 Methods of Using IGFIR and ABL Kinase Modulators Public/Granted day:2009-09-17
Information query
